Lawrence Steinman, Director at 180 Life Sciences Corp. (ATNF), bought 18,000 shares at $1.23 ($22K) on 2023-06-01, disclosed to the SEC on 2023-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| KTTA | BUY | 2023-06-06 | $13K | — | Filing → |
| ATNF | BUY | 2021-12-10 | $21K | — | Filing → |
| BCAB | SELL | 2021-11-03 | $14K | — | Filing → |